SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Heart failure linked to heavy energy drink consumption
Fri April 16th - Drinking excessive energy drinks could be linked to a young man’s heart failure, according to doctors who treated a 21-year-old who consumed four cans a day for two years. More
Shift workers' heart health linked to body clock
Fri April 16th - The risk of heart disease becomes greater the more an individual works outside of their natural body clock, new research suggests. More
Infection much greater risk than vaccines for thrombotic events
Fri April 16th - Cerebral venous thrombosis has been a significant complication of COVID-19 at a rate far higher than seen after vaccination, British researchers have reported. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Heart "revolution" hope

Tuesday November 15th, 2011

Patients with heart failure have successfully been treated with their own cells in a "revolutionary" treatment, researchers reported yesterday.

The success of the treatment offers fresh hope in the search to find ways of regenerating the diseased heart.

Some 16 patients were each treated with about a million stem cells, grown in a laboratory from material extracted from their own hearts.

The US project was the first to attempt to treat patients with their own heart cells - known as c-kit positive cells.

The findings of the "Scipio" project were reported to the conference of the American Heart Association in Florida, USA, yesterday - and are also reported in The Lancet.

According to the researchers, the patients enjoyed improvements averaging 12 per cent after a year - about three times what was expected.

Researcher Dr Roberto Bolli, of the University of Louisville, Kentucky, USA, said he hoped for the "biggest revolution" in heart treatment in his lifetime.

He said: "The results are striking. While we do not yet know why the improvement occurs, we have no doubt now that ejection fraction increased and scarring decreased.

"If these results hold up in future studies, I believe this could be the biggest revolution in cardiovascular medicine in my lifetime."

Professor Peter Weissberg, of the British Heart Foundation, warned that the study was not yet complete.

He said: “This is positive, but the crucial next steps are to see whether this improvement is confirmed in the final completed trial, and to understand whether the cells are actually replacing damaged heart cells or are secreting molecules that are helping to heal the heart."

Writing in The Lancet, Professor Gerd Heusch, University School of Medicine, Essen, Germany, talks of "new optimism" for the treatment.

He said: "We will have to see whether further data will meet the promises of the present study: more patients will need to be followed up over a longer period."

* The conference also heard of disappointing results from similar research using stem cells taken from bone marrow. The cells were injected shortly after patients suffered heart attacks in the hope of preventing heart failure.

Dr Susan Shurin, of the US National Heart, Blood and Lung Institute, said: "Stem cell therapy is a promising direction for repairing the damage done by a heart attack. We do not fully understand the optimal use of these cells."

* German researchers have identified a heart chemical that could play a key role in regenerating hearts.

Scientists at the Max Planck Institute for Heart and Lung Research , Bad Nauheim, say oncostatin M seems to play a key role in helping the heart heal itself.

The Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Roberto Bolli et al. Lancet November 14 2011 doi:10.1016/S0140-6736(11)61590-0

Tags: Heart Health | Internal Medicine | North America

Printer friendly page Printer friendly page

CATEGORIES